Written by Admin | Nov 12, 2021 5:00:00 AM
Study Background
- While manual histological evaluation of liver biopsy tissue is the gold-standard method for fibrosis and disease staging in nonalcoholic steatohepatitis (NASH),1 it is limited by inter- and intra-reader variability
- Machine learning models that have been trained to analyze and interpret liver
histopathology may help improve reproducibility of NASH grading and staging2
- In liver biopsy tissue, fibrosis staging and nonalcoholic fatty liver disease activity score (NAS) results determined by PathAI, a machine learning-based approach, have been shown to correlate with those obtained from manual interpretation2
- This exploratory post hoc analysis compared manual (single central reader) and PathAI pathology scoring of liver biopsy samples from patients with NASH and stage3 fibrosis in the phase 2b FALCON 1 study
References:
1. Chalasani N, et al. Hepatology. 2018;67(1):328–357.
2. Pokkalla H, et al. AASLD 2019. Abstract 187.
3. Abdelmalek MF, et al. Contemp Clin Trials. 2021;104:106335 Shevell et al.